Biotechnology Value Fund, which holds a 30 percent stake in Avigen, will finally get that special shareholders meeting it's been pushing for later this month. The firm is urging fellow stockholders to ...

District 8 City Council Member Manny Peláez and his law firm are on trial this week in U.S. Bankruptcy Court in San Antonio over whether they stiffed a business that provided property damage appraisal ...

This might explain why BVF Partners chose to sell at this time, potentially capitalizing on the stock's recent gains while the company maintains a solid cash position. However, it's worth noting that ...

ZURICH, SWITZERLAND / ACCESSWIRE / December 14, 2022 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP,)(NASDAQ:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company, focused on the ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

The investment by BVF Partners L.P. could be seen as a vote of confidence in Eledon's ongoing research and development efforts. Investors will be watching closely to see how this investment by BVF ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) (“Infinity”) today announced a $20 million non-dilutive asset-backed financing ...

While pledging its support to a merger offer by MediciNova Inc., Avigen shareholder Biotechnology Value Fund (BVF) offered to buy out Avigen shares at a price of $1 per share, with the aim of giving ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

In a recent transaction, BVF Partners L.P., a significant stakeholder in Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN), has invested an additional $5,931 through the purchase of pre-funded warrants. This ...